Anhui Ronds Science & Technology Incorporated Company

SSE:688768.SS

53.1 (CNY) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 83.574240.986122.804159.16560.776198.10193.896148.87657.165224.419113.235169.74139.636161.27592.588116.85226.381110.55261.32275.18916.715
Cost of Revenue 28.74581.66748.28959.46322.9575.77437.42254.96320.45273.6541.6165.22215.56368.83731.61745.1558.18434.14921.13922.3584.436
Gross Profit 54.829159.31974.51599.70237.825122.32756.47493.91336.713150.76971.625104.51924.07392.43860.97171.69718.19876.40340.18352.83112.279
Gross Profit Ratio 0.6560.6610.6070.6260.6220.6170.6010.6310.6420.6720.6330.6160.6070.5730.6590.6140.690.6910.6550.7030.735
Reseach & Development Expenses 26.70519.22630.38129.96427.59810.87335.43433.32629.49727.64326.91320.29117.1516.5116.53312.7712.87311.98410.8498.6998.6
General & Administrative Expenses 12.517-21.76826.424-0.89811.231-22.45430.467-1.2412.04-10.24319.8390.3168.293-10.31220.3911.9773.374-5.4316.1623.1182.469
Selling & Marketing Expenses 33.113-54.4175.24131.70829.00515.20236.89238.54829.30131.73733.56528.20625.31521.25723.77920.55918.32918.27514.21916.0119.687
SG&A 45.631-76.178101.66530.8140.236-7.25167.3637.30741.34121.49453.40428.52233.60810.94544.1722.53621.70212.84530.38119.12912.156
Other Expenses -6.38299.782-54.8580.0230.125-108.1870.2851.137-7.00413.352-16.034.489-2.5124.1391.166-0.449-0.1791.76320.918-0.6240.862
Operating Expenses 65.95442.82977.18870.61964.694108.18780.82479.10863.83362.48964.28753.30248.24636.96448.47832.85938.11835.46831.08525.14123.935
Operating Income -11.125116.49-2.67319.513-26.14289.914-23.0939.625-27.31380.8347.70249.129-24.17251.86413.48936.191-17.83537.0445.67527.555-10.504
Operating Income Ratio -0.1330.483-0.0220.123-0.430.454-0.2460.065-0.4780.360.0680.289-0.610.3220.1460.31-0.6760.3350.0930.366-0.628
Total Other Income Expenses Net 0.0611.9260.1150.0230.1250.9540.2851.1370.4370.0670.0123.8366.5864.1390.4470.0590.0314.10420.1450.1120.9
Income Before Tax -11.064118.416-2.55919.536-26.01790.992-22.80710.762-26.87680.9017.71352.966-17.58656.00213.93736.25-17.80441.14825.8227.667-9.604
Income Before Tax Ratio -0.1320.491-0.0210.123-0.4280.459-0.2430.072-0.470.360.0680.312-0.4440.3470.1510.31-0.6750.3720.4210.368-0.575
Income Tax Expense -4.67213.612-4.619-0.424-6.71511.805-7.626-7.807-7.1229.553-3.8426.281-4.0555.8270.8634.108-3.6485.3543.4693.798-2.006
Net Income -6.392104.8052.0619.96-19.30279.063-15.18118.569-19.75471.34711.55546.685-13.53150.17613.07432.142-14.15635.79322.35123.869-7.597
Net Income Ratio -0.0760.4350.0170.125-0.3180.399-0.1620.125-0.3460.3180.1020.275-0.3410.3110.1410.275-0.5370.3240.3640.317-0.455
EPS -0.071.210.0250.24-0.240.97-0.190.23-0.240.880.140.57-0.170.620.160.4-0.170.440.280.29-0.094
EPS Diluted -0.071.20.0250.24-0.240.96-0.190.23-0.240.860.140.57-0.170.620.160.4-0.170.440.280.29-0.094
EBITDA -11.055118.53-2.41319.493-22.43394.401-19.79710.836-26.49280.5910.74455.639-14.90358.74216.8338.432-17.00743.32127.89329.31-8.775
EBITDA Ratio -0.1320.492-0.020.122-0.3690.477-0.2110.073-0.4630.3590.0950.328-0.3760.3640.1820.329-0.6450.3920.4550.39-0.525